A profile of childhood neuropathies at a university hospital in Oman

Roshan Koul1, Alexander Chacko, Hashim Javed

  • 1Division of Pediatric Neurology, Child Health Ward (1), Sultan Qaboos University Hospital, Al Khod 123, Sultanate of Oman. roshankoul@hotmail.com

Saudi Medical Journal
|April 16, 2002
PubMed

Insights

Childhood neuropathies were analyzed, finding Acute Guillain-Barré syndrome most common. Treatable neuropathies comprised over half of cases in children under 14.

Area of Science:

  • Pediatric Neurology
  • Clinical Neuroscience
  • Peripheral Nerve Disorders

Background:

  • Childhood neuropathies present with diverse clinical features, including acute flaccid paralysis and chronic weakness.
  • Understanding the epidemiology and types of neuropathies in children is crucial for timely diagnosis and management.

Purpose of the Study:

  • To analyze the profile, pattern, clinical features, and management of childhood neuropathies in patients under 14 years of age.
  • To identify the most prevalent types of neuropathies and their underlying causes in a pediatric population.

Main Methods:

  • A retrospective and prospective study evaluated children with symptoms suggestive of neuropathy.
  • Data were collected from hospital medical records, pediatric neurology clinics, and neurophysiology labs.
  • Inclusion criteria covered acute flaccid paralysis, chronic weakness, neuroregression, and chemotherapy-induced neuropathy.

Main Results:

  • Eighty-two children were diagnosed with peripheral neuropathy.
  • Acute Guillain-Barré syndrome was the most frequent diagnosis (45.1%).
  • Genetic neuropathies (20.7% to 11%) and chronic inflammatory demyelinating neuropathy (6.1%) were also identified.

Conclusions:

  • Acute Guillain-Barré syndrome is the predominant acquired neuropathy in children.
  • Over half of the identified neuropathies were treatable, while a significant portion were preventable genetic conditions.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...